Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Siedlecki-Wullich D, Català-Solsona J, Fábregas C, Hernández I, Clarimon J, Lleó A, Boada M, Saura CA, Rodríguez-Álvarez J, Miñano-Molina AJ.

Alzheimers Res Ther. 2019 May 15;11(1):46. doi: 10.1186/s13195-019-0501-4.

2.

A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.

Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L, Zhao Y, Lu Z.

J Alzheimers Dis. 2017;60(4):1365-1377. doi: 10.3233/JAD-170343.

PMID:
29036818
3.

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.

Mol Neurobiol. 2017 Sep;54(7):5550-5562. doi: 10.1007/s12035-016-0088-8. Epub 2016 Sep 8.

PMID:
27631879
4.

Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.

Piscopo P, Grasso M, Puopolo M, D'Acunto E, Talarico G, Crestini A, Gasparini M, Campopiano R, Gambardella S, Castellano AE, Bruno G, Denti MA, Confaloni A.

J Alzheimers Dis. 2018;65(2):455-464. doi: 10.3233/JAD-180364.

PMID:
30056425
5.

MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.

Kumar S, Vijayan M, Reddy PH.

Hum Mol Genet. 2017 Oct 1;26(19):3808-3822. doi: 10.1093/hmg/ddx267.

6.

MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.

Satoh J, Kino Y, Niida S.

Biomark Insights. 2015 Apr 15;10:21-31. doi: 10.4137/BMI.S25132. eCollection 2015.

7.

Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.

Hara N, Kikuchi M, Miyashita A, Hatsuta H, Saito Y, Kasuga K, Murayama S, Ikeuchi T, Kuwano R.

Acta Neuropathol Commun. 2017 Jan 31;5(1):10. doi: 10.1186/s40478-017-0414-z.

8.

Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?

Yılmaz ŞG, Erdal ME, Özge AA, Sungur MA.

OMICS. 2016 Aug;20(8):456-61. doi: 10.1089/omi.2016.0099.

PMID:
27501295
9.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233. eCollection 2015.

10.

Plasma microRNA biomarkers for detection of mild cognitive impairment.

Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR.

Aging (Albany NY). 2012 Sep;4(9):590-605.

11.

Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.

Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN.

Mol Biol Rep. 2014 Jul;41(7):4513-9. doi: 10.1007/s11033-014-3322-3. Epub 2014 Mar 5.

PMID:
24595450
12.

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Kumar S, Reddy PH.

Biochim Biophys Acta. 2016 Sep;1862(9):1617-27. doi: 10.1016/j.bbadis.2016.06.001. Epub 2016 Jun 2. Review.

13.

Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.

Wu Y, Xu J, Xu J, Cheng J, Jiao D, Zhou C, Dai Y, Chen Q.

Tohoku J Exp Med. 2017 Jun;242(2):129-136. doi: 10.1620/tjem.242.129.

14.

Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.

Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L.

J Alzheimers Dis. 2014;40(4):1017-27. doi: 10.3233/JAD-132144.

PMID:
24577456
15.

miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.

Sørensen SS, Nygaard AB, Christensen T.

Transl Neurodegener. 2016 Mar 15;5:6. doi: 10.1186/s40035-016-0053-5. eCollection 2016.

16.

Serum miRNAs Expression and SNAP-25 Genotype in Alzheimer's Disease.

Agostini S, Mancuso R, Liuzzo G, Bolognesi E, Costa AS, Bianchi A, Clerici M.

Front Aging Neurosci. 2019 Mar 11;11:52. doi: 10.3389/fnagi.2019.00052. eCollection 2019.

17.

Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.

Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB.

BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.

18.

Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.

Mancuso R, Agostini S, Hernis A, Zanzottera M, Bianchi A, Clerici M.

Sci Rep. 2019 Jun 28;9(1):9393. doi: 10.1038/s41598-019-45687-x.

19.

Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.

Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.

Gene. 2018 Oct 5;673:181-193. doi: 10.1016/j.gene.2018.06.037. Epub 2018 Jun 18.

PMID:
29913239
20.

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.

Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z.

Int J Cancer. 2015 Oct 1;137(7):1679-90. doi: 10.1002/ijc.29544. Epub 2015 Apr 21.

Supplemental Content

Support Center